RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, Inc., a pioneer in regenerative medicine, has announced the completion of patient enrollment for two multi-center, investigative studies to assess the safety and efficacy of HumaGraft™, a bioengineered blood vessel.
Help employers find you! Check out all the jobs and post your resume.
